- Applications are now closed for 2020 research proposals. Thank you for all your proposals.
JP / EN
JP / EN
”ASAHI KASEI PHARMA OPEN INNOVATION” is an open innovation platform started in 2016 to recruit candidates for research collaborations related to drug discovery.
We aim to create innovative new drugs to match our corporate philosophy, ”contribute to life and living for people around the world”. Realizing this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.
We will accept a broad range of proposals from around the world based upon the program criteria presented in these pages. We would like to have candidates that will work together with our researchers, who are professionals in drug discovery research, to promote technological and drug discovery research with practical applications.
“Creating for tomorrow” with you.
We sincerely look forward to receiving your research proposals.
Asahi Kasei Pharma Corporation will offer selected candidates collaborative research opportunities, with research funding and contribution to the program through our scientists’ research activities.
If the program achieves progress, we will consider a separate license agreement that includes payments such as upfront, milestones, and royalties.
The results of the program performed in Japan via website are summarized below.
|For 2019||No. of proposals received||No. of deep reviews||No. of proposals adopted|
|Drug seeds＊ and Drug discovery technologies (Japan and International total)||104||14||
8(contracts under negotiation)
(as of Oct. 30, 2019)
|For 2018||No. of proposals received||No. of deep reviews||No. of proposals adopted|
|Drug seeds＊ and Drug discovery technologies (Japan)||36||9||6|
＊Drug seeds =drug target and drug candidate
Click “Apply” to proceed to the application form.